First patient receives potential new treatment for wet age-related macular degeneration in London Project to Cure Blindness.

A pioneering trial of a new treatment derived from stem cells for people with ‘wet’ age-related macular degeneration (AMD) has commenced at Moorfields Eye Hospital following a successful operation on a patient. This first operation is a major milestone in the London Project to Cure Blindness, which was established 8 years ago with the aim of curing vision loss in patients with wet AMD, and is the result of a partnership between the hospital, the UCL Institute of Ophthalmology, and the National Institute for Health Research (NIHR). Pfizer Inc. joined the partnership [in 2009] with the goal of helping to turn the original idea into a potential therapy.
See Press release in Latest News